BL
BioLife Sciences Inc.
BLFE · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $156.7K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
33 /100
Unstable Beta -2,290.12x
Profitable years 0
Rev. volatility N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BLFE
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Justin De Four
Employees
3
Headquarters
Henderson